Novartis challenges India’s patent law – Nature.com
Pharmaceutical giant Novartis goes to the Indian Supreme Court next week, aiming to weaken the country’s drug-patent law by challenging a clause that prevents ‘evergreening’, a practice in which pharma companies continuously extend the life of a ...
Subscribe to LegalLaw247.Com Newsletter